Annual report pursuant to Section 13 and 15(d)

Net Loss per Common Share (Details)

v3.20.1
Net Loss per Common Share (Details) - shares
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 18,293,739 17,682,146
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 849,186 886,682
Opus warrants to purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 1,880,000 1,880,000
Options to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 1,179,680 1,085,502
Convertible preferred stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 1,038,251 1,000,000
Unvested Restricted Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 12,625,144 11,174,113
Unvested Restricted Stock Units [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total of weighted average shares outstanding 721,478 1,655,849